Bellevue Group Ag Intercept Pharmaceuticals, Inc. Transaction History

Bellevue Group Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$15.46 - $24.5 $123,680 - $196,000	-8,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $17.1 Million - $29.6 Million	-696,976 Reduced 98.87%	8,000 $198,000
Q2 2020 Aug 13, 2020	SELL	$46.7 - $92.04 $186,800 - $368,160	-4,000 Reduced 0.56%	704,976 $33.8 Million
Q1 2020 May 14, 2020	SELL	$48.35 - $118.68 $299,770 - $735,816	-6,200 Reduced 0.87%	708,976 $44.6 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $745,680 - $1.61 Million	13,000 Added 1.85%	715,176 $88.6 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $565,008 - $774,588	-9,627 Reduced 1.35%	702,176 $46.6 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $54 Million - $83.8 Million	694,576 Added 4031.9%	711,803 $56.6 Million
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $543,725 - $714,546	-5,921 Reduced 25.58%	17,227 $1.93 Million
Q4 2018 Feb 12, 2019	SELL	$85.79 - $126.46 $85,790 - $126,460	-1,000 Reduced 4.14%	23,148 $2.33 Million
Q3 2018 Nov 13, 2018	SELL	$88.49 - $127.55 $44,245 - $63,775	-500 Reduced 2.03%	24,148 $3.05 Million
Q2 2018 Aug 07, 2018	SELL	$60.0 - $85.67 $435,120 - $621,278	-7,252 Reduced 22.73%	24,648 $2.07 Million
Q1 2018 May 09, 2018	BUY	$52.72 - $67.25 $659,000 - $840,625	12,500 Added 64.43%	31,900 $1.96 Million
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $634,380 - $793,084	10,900 Added 128.24%	19,400 $1.13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	8,500	8,500 $1.03 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.